Purinergic signaling in epilepsy

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Epilepsy treatment traditionally focuses on neuronal dysfunction, with limited success in one-third of patients.
• A neurocentric view is insufficient; glial cell-neuron interactions are critical for brain function and dysfunction.
• Astrocytes and microglial cells are increasingly implicated in epilepsy progression, even at early stages.

Purpose of the Study:

• To review recent findings on the involvement of glial cells in epilepsy.
• To highlight the role of purinergic signaling in neuron-glia interactions in the epileptic brain.
• To discuss the potential of astrocytic and microglial P2X and P2Y receptors as therapeutic targets.

Main Methods:

• Review of experimental data and current knowledge on epilepsy mechanisms.
• Analysis of animal models and human disease studies.
• Focus on purinergic signaling pathways and P2X/P2Y receptors in glial cells.

Main Results:

• Experimental evidence supports the significant involvement of astrocytes and microglial cells in epilepsy.
• Purinergic signaling is a key component of neuron-glia communication and is altered in epilepsy.
• Astrocytic and microglial P2X and P2Y receptors are implicated in the functional remodeling of the epileptic brain.

Conclusions:

• Glial cells, especially astrocytes and microglia, are integral to epilepsy pathogenesis.
• Modifications in purinergic signaling pathways are critical in the epileptic brain.
• Targeting astrocytic and microglial P2X and P2Y receptors presents promising new therapeutic strategies for epilepsy.